Lead fluid biomarker strategy for clinical programs, ensuring alignment with clinical objectives, regulatory expectations, and translational hypotheses.
Design and oversee development, qualification, and validation of biomarker assays at CROs and external laboratory partners.
Provide scientific oversight for assay selection, fit-for-purpose validation, and performance monitoring.
Contribute to clinical protocol development, statistical analysis plans, and regulatory documents (e.g., INDs, briefing books).
Direct development and validation/qualification of blood-based and other fluid biomarker assays (e.g., protein, enzymatic, molecular assays).
Ensure assays are developed under appropriate regulatory frameworks (GLP/GCLP/CLIA as applicable).
Evaluate assay performance characteristics including sensitivity, specificity, precision, robustness, and stability.
Troubleshoot assay performance issues and implement corrective actions.
Partner closely with clinical operations and sample management teams to ensure seamless biomarker sample collection, handling, and analysis.
Collaborate with peers responsible for immunogenicity and PK assays to ensure integrated PK/PD and biomarker analysis.
Oversee data generation timelines, budgets, and vendor performance.
Lead scientific review and interpretation of biomarker data to support internal decision-making.
Work closely with Clinical Development, Regulatory, Biostatistics, CMC, and Research teams.
Contribute to cross-program biomarker governance and best practices.
Represent the Biomarkers group in cross-functional team meetings and external vendor discussions.
Perform and/or oversee robust statistical and scientific analysis of biomarker data.
Integrate biomarker findings with clinical endpoints and PK data.
Prepare high-quality summaries and presentations for internal governance and external regulatory interactions.
Qualifications
Required: PhD in Immunology, Molecular Biology, Biochemistry, Translational Medicine, or related discipline with 4+ years of industry experience; or MS with 8+ years of relevant industry experience.
Preferred: Exposure to multiplexed, LC/MS-based, or advanced molecular biomarker platforms.
Education
PhD in Immunology, Molecular Biology, Biochemistry, Translational Medicine, or related discipline with 4+ years of industry experience; or MS with 8+ years of relevant industry experience.